Results 61 to 70 of about 9,669 (183)
Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez +3 more
wiley +1 more source
Background: Aspergillus fumigatus leads to serious systemic infections in immunocompromised patients, thereby emphasizing the need for novel immunomodulatory therapies acting on both innate (sCD14) and adaptive (IL-21) immune systems.
Mustafa Abdul Kareem Hameed +2 more
doaj +1 more source
mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics
This review highlights the transformative potential of mRNA cancer vaccines, leveraging technological advancements in nucleotide modification, lipid nanoparticle delivery, and AI‐driven neoantigen selection to enhance vaccine stability, immunogenicity, and personalization.
Bo Yang, Juan Liu, Yang Li, Xiaoxuan Liu
wiley +1 more source
OBSERVATIONS ON DIPHTHERIA TOXOID AS AN IMMUNIZING AGENT
water vehicles and has proved to be very economical, easy to perform, reliable and consistent in results, and is adaptable to the testing of materials with organic matter as well as those without. In the examination of materials selective for gram negative organisms, as acriflavine, the colon bacilli can be very properly substituted as a test organism,
W H, Park +3 more
openaire +3 more sources
ABSTRACT Janus kinase inhibitors (JAKIs) are immunomodulatory drugs used for autoimmune and inflammatory conditions. Their potential impact on pregnancy and fetal development remains a concern due to placental transfer and potential disruption of cytokine and growth factor signaling, with limited human data.
Nazanin Abolhassani +7 more
wiley +1 more source
Is Diphtheria Booster Vaccination Still Necessary in Turkey?
Introduction: Diphtheria is a serious disease that can be prevented by vaccination. The aim of the study was to determine immunity against diphtheria and the necessity of booster doses in the adult population.Materials and Methods: Serum antibody levels ...
Sule Eren CAKAR +5 more
doaj +1 more source
Background: Limited data exists regarding population immunity against diphtheria, tetanus, and pertussis in Thailand during the post-COVID-19 pandemic period. This study aimed to evaluate the age-specific seroprevalence of anti-diphtheria toxoid (anti-DT)
Nasamon Wanlapakorn +21 more
doaj +1 more source
Although the safety profile of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in adolescents and adults has been documented, few data have reported about their adverse events in children.
Sung-Hsi Wei +4 more
doaj +1 more source
Evaluation of Biodegradable Microparticles for Mucosal Vaccination Against Diphtheria Toxoid: Nasal Efficacy Studies in Guinea Pigs. [PDF]
Çoban S, Saka OM, Bozkır A.
europepmc +1 more source
Purification of diphtheria toxoid [PDF]
P J, Moloney, M D, Orr
openaire +2 more sources

